[go: up one dir, main page]

HUE058263T2 - Mutációk detektálása rákszûrési és magzatelemzési célból - Google Patents

Mutációk detektálása rákszûrési és magzatelemzési célból

Info

Publication number
HUE058263T2
HUE058263T2 HUE16748745A HUE16748745A HUE058263T2 HU E058263 T2 HUE058263 T2 HU E058263T2 HU E16748745 A HUE16748745 A HU E16748745A HU E16748745 A HUE16748745 A HU E16748745A HU E058263 T2 HUE058263 T2 HU E058263T2
Authority
HU
Hungary
Prior art keywords
cancer screening
detecting mutations
fetal analysis
fetal
analysis
Prior art date
Application number
HUE16748745A
Other languages
English (en)
Inventor
Yuk-Ming Dennis Lo
Rossa Wai Kwun Chiu
Kwan Chee Chan
Peiyong Jiang
Original Assignee
Univ Hong Kong Chinese
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Hong Kong Chinese filed Critical Univ Hong Kong Chinese
Publication of HUE058263T2 publication Critical patent/HUE058263T2/hu

Links

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/50Mutagenesis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/10Sequence alignment; Homology search
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Medical Informatics (AREA)
  • Theoretical Computer Science (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
HUE16748745A 2015-02-10 2016-02-14 Mutációk detektálása rákszûrési és magzatelemzési célból HUE058263T2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562114471P 2015-02-10 2015-02-10
US201562271196P 2015-12-22 2015-12-22

Publications (1)

Publication Number Publication Date
HUE058263T2 true HUE058263T2 (hu) 2022-07-28

Family

ID=56615337

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE16748745A HUE058263T2 (hu) 2015-02-10 2016-02-14 Mutációk detektálása rákszûrési és magzatelemzési célból

Country Status (14)

Country Link
US (3) US10240209B2 (hu)
EP (2) EP4012715B1 (hu)
JP (3) JP6829211B2 (hu)
KR (1) KR20170125044A (hu)
CN (2) CN107771221B (hu)
AU (2) AU2016218631B2 (hu)
CA (1) CA2976303A1 (hu)
DK (1) DK3256605T3 (hu)
ES (1) ES2908347T3 (hu)
HU (1) HUE058263T2 (hu)
PT (1) PT3256605T (hu)
SG (1) SG11201706529TA (hu)
TW (3) TWI740817B (hu)
WO (1) WO2016127944A1 (hu)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI335354B (en) 2006-09-27 2011-01-01 Univ Hong Kong Chinese Methods for the detection of the degree of the methylation of a target dna and kits
WO2012129363A2 (en) 2011-03-24 2012-09-27 President And Fellows Of Harvard College Single cell nucleic acid detection and analysis
US9892230B2 (en) 2012-03-08 2018-02-13 The Chinese University Of Hong Kong Size-based analysis of fetal or tumor DNA fraction in plasma
EP4424826A3 (en) 2012-09-04 2024-11-27 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
US10876152B2 (en) 2012-09-04 2020-12-29 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
US20160040229A1 (en) 2013-08-16 2016-02-11 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
US11913065B2 (en) 2012-09-04 2024-02-27 Guardent Health, Inc. Systems and methods to detect rare mutations and copy number variation
WO2014093330A1 (en) 2012-12-10 2014-06-19 Clearfork Bioscience, Inc. Methods for targeted genomic analysis
SG11201604923XA (en) 2013-12-28 2016-07-28 Guardant Health Inc Methods and systems for detecting genetic variants
WO2016008451A1 (en) 2014-07-18 2016-01-21 The Chinese University Of Hong Kong Methylation pattern analysis of tissues in dna mixture
KR102696857B1 (ko) 2014-07-25 2024-08-19 유니버시티 오브 워싱톤 무세포 dna를 생성하는 조직 및/또는 세포 유형을 결정하는 방법 및 이를 사용하여 질환 또는 장애를 확인하는 방법
US20160053301A1 (en) 2014-08-22 2016-02-25 Clearfork Bioscience, Inc. Methods for quantitative genetic analysis of cell free dna
US10364467B2 (en) 2015-01-13 2019-07-30 The Chinese University Of Hong Kong Using size and number aberrations in plasma DNA for detecting cancer
ES2908347T3 (es) 2015-02-10 2022-04-28 Univ Hong Kong Chinese Detección de mutaciones para cribado de cáncer y análisis fetal
PT3967775T (pt) 2015-07-23 2023-10-10 Univ Hong Kong Chinese Análise de padrões de fragmentação de adn sem células
IL285202B2 (en) 2015-11-11 2025-03-01 Resolution Bioscience Inc High-efficiency construction of DNA libraries
JP2019507585A (ja) 2015-12-17 2019-03-22 ガーダント ヘルス, インコーポレイテッド 無細胞dnaの分析による腫瘍遺伝子コピー数を決定するための方法
US11514289B1 (en) 2016-03-09 2022-11-29 Freenome Holdings, Inc. Generating machine learning models using genetic data
EP3427183A1 (en) * 2016-03-10 2019-01-16 Genomic Vision Method of curvilinear signal detection and analysis and associated platform
EP3497220A4 (en) 2016-08-10 2020-04-01 Grail, Inc. METHODS OF PREPARING DOUBLE-INDEXING DNA LIBRARIES FOR BISULPHITE CONVERSION SEQUENCING
MX2019002093A (es) 2016-08-25 2019-06-20 Resolution Bioscience Inc Métodos para la detección de cambios de copia genómica en muestras de adn.
KR20240155386A (ko) 2016-09-30 2024-10-28 가던트 헬쓰, 인크. 무세포 핵산의 다중-해상도 분석 방법
US9850523B1 (en) 2016-09-30 2017-12-26 Guardant Health, Inc. Methods for multi-resolution analysis of cell-free nucleic acids
EP3535415A4 (en) 2016-10-24 2020-07-01 The Chinese University of Hong Kong TUMOR DETECTION METHODS AND SYSTEMS
AU2017369018B2 (en) 2016-11-30 2021-02-25 The Chinese University Of Hong Kong Analysis of cell-free DNA in urine and other samples
WO2018119216A1 (en) * 2016-12-21 2018-06-28 The Regents Of The University Of California Deconvolution and detection of rare dna in plasma
WO2018137685A1 (en) 2017-01-25 2018-08-02 The Chinese University Of Hong Kong Diagnostic applications using nucleic acid fragments
EP3366780B1 (en) 2017-02-23 2020-05-06 Siemens Healthcare GmbH Single-molecule sequence and high sensitivity methylation analysis for tissue-specific analysis
IT201700045353A1 (it) * 2017-04-26 2018-10-26 Bioscience Services S R L Metodo per la ricerca e l'individuazione di una condizione genetica prodromica all'insorgenza di tumori solidi
WO2018213498A1 (en) * 2017-05-16 2018-11-22 Guardant Health, Inc. Identification of somatic or germline origin for cell-free dna
US10081829B1 (en) 2017-06-13 2018-09-25 Genetics Research, Llc Detection of targeted sequence regions
US10636512B2 (en) 2017-07-14 2020-04-28 Cofactor Genomics, Inc. Immuno-oncology applications using next generation sequencing
EP3431610A1 (en) * 2017-07-19 2019-01-23 Noscendo GmbH Methods and devices for nucleic acid-based real-time determination of disease states
CN111051536A (zh) 2017-07-26 2020-04-21 香港中文大学 利用不含细胞的病毒核酸改善癌症筛选
US20190108311A1 (en) * 2017-10-06 2019-04-11 Grail, Inc. Site-specific noise model for targeted sequencing
JP7421474B2 (ja) 2017-11-03 2024-01-24 ガーダント ヘルス, インコーポレイテッド 腫瘍遺伝子変異量の正規化
US12367978B2 (en) 2017-12-01 2025-07-22 Illumina, Inc. Methods and systems for determining somatic mutation clonality
SG11202006542XA (en) * 2018-01-12 2020-08-28 Grail Inc Methods for analyzing viral nucleic acid
CN119753091A (zh) 2018-04-02 2025-04-04 格里尔公司 用于扩增与癌症相关联的cfDNA分子的化验板
US20210158895A1 (en) * 2018-04-13 2021-05-27 Dana-Farber Cancer Institute, Inc. Ultra-sensitive detection of cancer by algorithmic analysis
US20210104297A1 (en) * 2018-04-16 2021-04-08 Grail, Inc. Systems and methods for determining tumor fraction in cell-free nucleic acid
EP3784806A4 (en) * 2018-04-24 2022-01-19 Grail, LLC SYSTEMS AND METHODS OF USING A PATHOGENIC NUCLEIC ACID LOAD TO DETERMINE IF A SUBJECT HAS A CANCER CONDITION
CN108900319B (zh) * 2018-05-30 2021-05-25 北京百度网讯科技有限公司 故障检测方法和装置
CN112752854B (zh) * 2018-07-23 2025-03-18 夸登特健康公司 用于通过肿瘤分数和覆盖率调整肿瘤突变负荷的方法和系统
WO2020023671A1 (en) * 2018-07-24 2020-01-30 Protocol Intelligence, Inc. Methods and systems for treating cancer and predicting and optimizing treatment outcomes in individual cancer patients
CA3106820A1 (en) * 2018-07-26 2020-01-30 Lexent Bio, Inc. Multiple sequencing using a single flow cell
CN109022619A (zh) * 2018-08-27 2018-12-18 郑州安图生物工程股份有限公司 一种用于检测人类疱疹病毒4型的试剂盒
EP3856903A4 (en) 2018-09-27 2022-07-27 Grail, LLC METHYLATION MARKER AND TARGETED METHYLATION PROBE PANEL
CN113168885B (zh) * 2018-11-13 2024-07-16 麦利亚德基因公司 用于体细胞突变的方法和系统及其用途
CA3123474A1 (en) * 2018-12-19 2020-06-25 The Chinese University Of Hong Kong Cell-free dna end characteristics
ES3013495T3 (en) 2019-01-31 2025-04-14 Guardant Health Inc Method for isolating and sequencing cell-free dna
CN109841265B (zh) * 2019-02-22 2021-09-21 清华大学 使用片段化模式确定血浆游离核酸分子组织来源的方法和系统及应用
US12497662B2 (en) 2019-04-16 2025-12-16 Grail, Inc. Systems and methods for tumor fraction estimation from small variants
WO2020236941A1 (en) * 2019-05-20 2020-11-26 Foundation Medicine, Inc. Systems and methods for evaluating tumor fraction
KR20220013349A (ko) * 2019-06-03 2022-02-04 일루미나, 인코포레이티드 검출 한계 기반 품질 제어 메트릭
AU2020297585A1 (en) * 2019-06-21 2022-01-20 Coopersurgical, Inc. Systems and methods for using density of single nucleotide variations for the verification of copy number variations in human embryos
US20210065842A1 (en) * 2019-07-23 2021-03-04 Grail, Inc. Systems and methods for determining tumor fraction
JP2022544626A (ja) * 2019-08-19 2022-10-19 グリーン クロス ゲノム コーポレーション 核酸断片間距離情報を用いた染色体異常検出方法
KR102835853B1 (ko) * 2019-10-08 2025-07-17 일루미나, 인코포레이티드 클론성 조혈증으로부터의 세포 유리 dna 돌연변이의 단편 크기 특성화
WO2021137770A1 (en) * 2019-12-30 2021-07-08 Geneton S.R.O. Method for fetal fraction estimation based on detection and interpretation of single nucleotide variants
JP2023510318A (ja) * 2020-01-08 2023-03-13 ザ チャイニーズ ユニバーシティ オブ ホンコン 無細胞試料の二末端dna断片タイプおよびその用途
US11211144B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Methods and systems for refining copy number variation in a liquid biopsy assay
US11475981B2 (en) 2020-02-18 2022-10-18 Tempus Labs, Inc. Methods and systems for dynamic variant thresholding in a liquid biopsy assay
US11211147B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing
US20220177971A1 (en) * 2020-12-08 2022-06-09 The Chinese University Of Hong Kong Methods using characteristics of urinary and other dna
CN113628683B (zh) * 2021-08-24 2024-04-09 慧算医疗科技(上海)有限公司 一种高通量测序突变检测方法、设备、装置及可读存储介质
US20230207128A1 (en) * 2021-12-29 2023-06-29 AiOnco, Inc. Processing encrypted data for artificial intelligence-based analysis
CN114582429B (zh) * 2022-03-03 2023-06-13 四川大学 基于层次注意力神经网络的结核分枝杆菌耐药性预测方法及装置
KR102491322B1 (ko) * 2022-03-29 2023-01-27 주식회사 아이엠비디엑스 암 진단을 위한 다중 분석 예측 모델의 제조 방법
EP4526481A2 (en) * 2022-05-19 2025-03-26 Personalis, Inc. Methods and system for using methylation data for disease detection and quantification
CN115394358B (zh) * 2022-08-31 2023-05-12 西安理工大学 基于深度学习的单细胞测序基因表达数据插补方法和系统
EP4567818A4 (en) * 2022-09-09 2025-12-17 Nanjing Genscript Biotech Co Ltd METHOD FOR DESIGNING A SEQUENCE OF HUMANIZED ANTIBODY
CN115424666B (zh) * 2022-09-13 2023-07-11 江苏先声医学诊断有限公司 一种基于全基因组重亚硫酸盐测序数据筛选泛癌早筛分子标志物的方法及系统
JP7736309B2 (ja) * 2022-11-18 2025-09-09 株式会社ニューギン 遊技機
JP7736308B2 (ja) * 2022-11-18 2025-09-09 株式会社ニューギン 遊技機
JP7736307B2 (ja) * 2022-11-18 2025-09-09 株式会社ニューギン 遊技機
JP7736310B2 (ja) * 2022-11-18 2025-09-09 株式会社ニューギン 遊技機
US20240229149A1 (en) * 2023-01-09 2024-07-11 Clearnote Health, Inc. 5-HYDROXYMETHYLATION ANALYSIS OF BUFFY COAT gDNA IN CANCER DETECTION
WO2025054456A1 (en) * 2023-09-08 2025-03-13 Ellison Institute, Llc Methods of determining variability in molecular alterations

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1169347B1 (en) 1999-04-02 2008-07-02 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US20030219765A1 (en) 2000-03-23 2003-11-27 Jose Costa Methods for evaluating cancer risk
WO2003062441A1 (en) 2002-01-18 2003-07-31 Genzyme Corporation Methods for fetal dna detection and allele quantitation
US7704687B2 (en) 2002-11-15 2010-04-27 The Johns Hopkins University Digital karyotyping
AU2004217872B2 (en) 2003-03-05 2010-03-25 Genetic Technologies Limited Identification of fetal DNA and fetal cell markers in maternal plasma or serum
PL201608B1 (pl) 2003-06-13 2009-04-30 Cezary Cybulski Sposób i zestaw do wykrywania wysokiej genetycznie uwarunkowanej predyspozycji do raka prostaty oraz zastosowanie zmiany germinalnej w obrębie genu NBS1
DE60328193D1 (de) 2003-10-16 2009-08-13 Sequenom Inc Nicht invasiver Nachweis fötaler genetischer Merkmale
CA2562310A1 (en) 2004-04-30 2005-11-17 Yale University Methods and compositions for cancer diagnosis
US20070122823A1 (en) 2005-09-01 2007-05-31 Bianchi Diana W Amniotic fluid cell-free fetal DNA fragment size pattern for prenatal diagnosis
EP2385143B1 (en) 2006-02-02 2016-07-13 The Board of Trustees of the Leland Stanford Junior University Non-invasive fetal genetic screening by digital analysis
SI2351858T1 (sl) 2006-02-28 2015-06-30 University Of Louisville Research Foundation Med Center Three, Zaznavanje fetalnih kromosomskih nenormalnosti z uporabo tandema polimorfizmov posameznih nukleotidov
EA010571B1 (ru) 2006-08-15 2008-10-30 Институт Молекулярной Генетики Российской Академии Наук (Имг Ран) Способ диагностики немелкоклеточного рака легких и набор для его осуществления
US8580501B2 (en) 2007-05-25 2013-11-12 Decode Genetics Ehf. Genetic variants on chr 5p12 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment
CN106834481A (zh) 2007-07-23 2017-06-13 香港中文大学 用于分析遗传变异的方法
US20090053719A1 (en) 2007-08-03 2009-02-26 The Chinese University Of Hong Kong Analysis of nucleic acids by digital pcr
US20100041048A1 (en) 2008-07-31 2010-02-18 The Johns Hopkins University Circulating Mutant DNA to Assess Tumor Dynamics
ES2620294T3 (es) 2008-09-20 2017-06-28 The Board Of Trustees Of The Leland Stanford Junior University Diagnóstico no invasivo de la aneuploidia fetal por secuenciación
US20100136560A1 (en) 2008-12-02 2010-06-03 The Johns Hopkins University Integrated Analyses of Breast and Colorectal Cancers
US20120021428A1 (en) 2009-03-31 2012-01-26 Marcus Otte Method for diagnosis of cancer and monitoring of cancer treatments
WO2011038507A1 (en) 2009-10-02 2011-04-07 Centre For Addiction And Mental Health Method for analysis of dna methylation profiles of cell-free circulating dna in bodily fluids
WO2011053790A2 (en) 2009-10-30 2011-05-05 Fluidigm Corporation Assay of closely linked targets in fetal diagnosis and coincidence detection assay for genetic analysis
EP2496717B1 (en) 2009-11-05 2017-06-07 The Chinese University of Hong Kong Fetal genomic analysis from a maternal biological sample
ES3026544T3 (en) 2009-11-06 2025-06-11 Univ Hong Kong Chinese Size-based genomic analysis for prenatal diagnosis
GB0922006D0 (en) 2009-12-17 2010-02-03 Genome Res Ltd Diagnostic
AU2010343276B2 (en) 2010-01-19 2015-05-28 Verinata Health, Inc. Methods for determining fraction of fetal nucleic acid in maternal samples
EP2513341B1 (en) 2010-01-19 2017-04-12 Verinata Health, Inc Identification of polymorphic sequences in mixtures of genomic dna by whole genome sequencing
EP2536854B1 (en) 2010-02-18 2017-07-19 The Johns Hopkins University Personalized tumor biomarkers
EP2426217A1 (en) 2010-09-03 2012-03-07 Centre National de la Recherche Scientifique (CNRS) Analytical methods for cell free nucleic acids and applications
KR102040307B1 (ko) 2010-11-30 2019-11-27 더 차이니즈 유니버시티 오브 홍콩 암과 연관된 유전적 또는 분자적 이상들의 검출
KR101974492B1 (ko) 2011-07-26 2019-05-02 베리나타 헬스, 인코포레이티드 샘플 중 상이한 이수성의 존재 또는 부재를 결정하는 방법
WO2013052913A2 (en) 2011-10-06 2013-04-11 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
WO2013086352A1 (en) 2011-12-07 2013-06-13 Chronix Biomedical Prostate cancer associated circulating nucleic acid biomarkers
US9892230B2 (en) 2012-03-08 2018-02-13 The Chinese University Of Hong Kong Size-based analysis of fetal or tumor DNA fraction in plasma
US9862995B2 (en) 2012-03-13 2018-01-09 Abhijit Ajit Patel Measurement of nucleic acid variants using highly-multiplexed error-suppressed deep sequencing
KR20150028256A (ko) 2012-05-31 2015-03-13 스미토모 덴키 고교 가부시키가이샤 산화물 초전도 박막과 그의 제조 방법
US11261494B2 (en) 2012-06-21 2022-03-01 The Chinese University Of Hong Kong Method of measuring a fractional concentration of tumor DNA
EP4424826A3 (en) * 2012-09-04 2024-11-27 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
US9732390B2 (en) 2012-09-20 2017-08-15 The Chinese University Of Hong Kong Non-invasive determination of methylome of fetus or tumor from plasma
CA2884066C (en) 2012-09-20 2021-08-10 The Chinese University Of Hong Kong Non-invasive determination of methylome of fetus or tumor from plasma
CN105339507A (zh) * 2013-02-21 2016-02-17 托马生物科学公司 用于核酸分析的方法、组合物和试剂盒
CA2906818C (en) 2013-03-15 2022-08-16 Verinata Health, Inc. Generating cell-free dna libraries directly from blood
US10174375B2 (en) * 2013-09-20 2019-01-08 The Chinese University Of Hong Kong Sequencing analysis of circulating DNA to detect and monitor autoimmune diseases
US10262755B2 (en) * 2014-04-21 2019-04-16 Natera, Inc. Detecting cancer mutations and aneuploidy in chromosomal segments
US20160002717A1 (en) 2014-07-02 2016-01-07 Boreal Genomics, Inc. Determining mutation burden in circulating cell-free nucleic acid and associated risk of disease
KR102696857B1 (ko) 2014-07-25 2024-08-19 유니버시티 오브 워싱톤 무세포 dna를 생성하는 조직 및/또는 세포 유형을 결정하는 방법 및 이를 사용하여 질환 또는 장애를 확인하는 방법
EP3224380A1 (en) 2014-11-25 2017-10-04 The Broad Institute Inc. Clonal haematopoiesis
ES2989276T3 (es) 2014-12-05 2024-11-25 Found Medicine Inc Análisis multigénico de muestras tumorales
EP4574996B1 (en) 2014-12-31 2025-11-05 Guardant Health, Inc. Detection and treatment of disease exhibiting disease cell heterogeneity and systems and methods for communicating test results
ES2908347T3 (es) 2015-02-10 2022-04-28 Univ Hong Kong Chinese Detección de mutaciones para cribado de cáncer y análisis fetal
WO2016149261A1 (en) 2015-03-16 2016-09-22 Personal Genome Diagnostics, Inc. Systems and methods for analyzing nucleic acid

Also Published As

Publication number Publication date
JP2022185149A (ja) 2022-12-13
SG11201706529TA (en) 2017-09-28
TWI817187B (zh) 2023-10-01
PT3256605T (pt) 2022-03-17
AU2022203114A1 (en) 2022-05-26
HK1244515A1 (zh) 2018-08-10
CA2976303A1 (en) 2016-08-18
HK1251018A1 (zh) 2019-01-18
EP3256605B1 (en) 2022-02-09
EP3256605A1 (en) 2017-12-20
TW201700732A (zh) 2017-01-01
US20170073774A1 (en) 2017-03-16
CN113957124A (zh) 2022-01-21
TWI740817B (zh) 2021-10-01
JP2021061861A (ja) 2021-04-22
EP4012715A1 (en) 2022-06-15
ES2908347T3 (es) 2022-04-28
US10240209B2 (en) 2019-03-26
JP6829211B2 (ja) 2021-02-10
WO2016127944A1 (en) 2016-08-18
US20190153541A1 (en) 2019-05-23
DK3256605T3 (da) 2022-03-14
EP4012715B1 (en) 2025-09-24
TW202400808A (zh) 2024-01-01
TW202146657A (zh) 2021-12-16
CN107771221B (zh) 2021-11-02
JP7168247B2 (ja) 2022-11-09
KR20170125044A (ko) 2017-11-13
CN107771221A (zh) 2018-03-06
AU2016218631A1 (en) 2017-08-17
AU2016218631B2 (en) 2022-03-10
US20220127683A1 (en) 2022-04-28
EP3256605A4 (en) 2018-10-17
US11168370B2 (en) 2021-11-09
JP2018512048A (ja) 2018-05-10

Similar Documents

Publication Publication Date Title
SG11201706529TA (en) Detecting mutations for cancer screening and fetal analysis
ZA201706572B (en) Devices and methods for sample analysis
SG10201408391RA (en) Means and methods for multimodality analysis and processing ofdrilling mud
SI3234184T1 (sl) Postopki za detekcijo CPG metilacije in za diagnosticiranje raka
SG11201706341RA (en) Systems and methods for biological analysis
SG11201706367WA (en) Systems and methods for assessing biological samples
IL255346A0 (en) Liposomal preparations for non-invasive prenatal or cancer screening
IL242550B (en) Testing and classification system
GB2559921B (en) Measuring reagent and analysis device for analyzing biopolymer
SG10201601097XA (en) Amplitude-versus-angle analysis for quantitative interpretation
PL3336514T3 (pl) Próbnik do analizy bezpośredniej
GB201419814D0 (en) Data traffic processing and analysis
GB201407641D0 (en) Fluidic analysis and separation
PL3336511T3 (pl) Urządzenie do pobierania próbek do bezpośredniej analizy
GB201503364D0 (en) A device for receiving and analysing a sample
GB201401626D0 (en) Audio signal analysis
SG11201707461YA (en) Sample collection and separation device
GB201611057D0 (en) Spectroscopic analysis
GB2558160B (en) Shaker imaging and analysis
SG10201605375YA (en) Sample holder and sample holder set
HUE045901T2 (hu) Analizáló berendezés víz- és szennyvízanalízishez
GB201504569D0 (en) Tissue sample analysis technique
SG11201708795TA (en) Analyte detection and methods therefor
EP3137109A4 (en) Methods and compositions for screening and detecting cancer
EP3405095C0 (en) TISSUE SAMPLE ANALYSIS